Compounding: How Does FDA Expand Oversight Without Legislation?
This article was originally published in The Gold Sheet
Executive Summary
After House Republicans indicate legislation expanding agency’s oversight of compounding is unlikely, FDA could consider other regulatory options, like changing internal policies or hoping a court clarifies its regulatory authority.